Last C$0.60 CAD
Change Today 0.00 / 0.00%
Volume 67.2K
OPS On Other Exchanges
Symbol
Exchange
OTC US
As of 3:00 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

opsens inc (OPS) Snapshot

Open
C$0.57
Previous Close
C$0.60
Day High
C$0.60
Day Low
C$0.57
52 Week High
01/10/14 - C$0.93
52 Week Low
07/28/14 - C$0.53
Market Cap
36.1M
Average Volume 10 Days
31.0K
EPS TTM
C$-0.06
Shares Outstanding
60.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OPSENS INC (OPS)

Related News

No related news articles were found.

opsens inc (OPS) Related Businessweek News

No Related Businessweek News Found

opsens inc (OPS) Details

Opsens Inc. develops, manufactures, supplies, and installs systems for measuring parameters of pressure, temperature, and others in Canada, the United States, and internationally. The company operates through Opsens and Opsens Solutions segments. It develops, produces, and supplies fiber optic sensors; and specializes in the commercialization and installation of optical and conventional sensors for the oil and gas industry in Alberta. The company also provides temperature, pressure, strain, and displacement solutions for life sciences, medical, transformer, defense, aerospace, semiconductor, civil engineering, microwave chemistry, food, industry, and laboratory sectors; and signal conditioners and original equipment manufacturer cards. In addition, it offers oil and gas products, such as optical sensors for harsh environments, surface controller units, and fiber optic cables; and downhole fiber optic pressure and temperature sensing solutions, reservoir surveillance design solutions, reservoir engineering services, and monitoring diagnostic services. Further, the company provides OptoWire One, a fractional flow reserve (FFR) guide wire; and OptoMonitor, a cathlab integration and intuitive workflow system that offers display with navigation and option for USB data storage or FFR paper printouts. Opsens Inc. is headquartered in Québec, Canada.

52 Employees
Last Reported Date: 11/26/14

opsens inc (OPS) Top Compensated Officers

President, Chief Executive Officer and Direct...
Total Annual Compensation: C$155.0K
Chief Financial Officer and Corporate Secreta...
Total Annual Compensation: C$93.3K
President of Opsens Solutions Inc
Total Annual Compensation: C$180.0K
Vice President of Oil & Gas, Director and Dir...
Total Annual Compensation: C$155.0K
Vice President of Medical, Director and Membe...
Total Annual Compensation: C$155.0K
Compensation as of Fiscal Year 2013.

opsens inc (OPS) Key Developments

Opsens Inc. Reports Earnings Results for the Fourth Quarter and Year Ended August 31, 2014

Opsens Inc. reported earnings results for the fourth quarter and year ended August 31, 2014. For the quarter, the company reported sales reached CAD 1,804,000 compared with CAD 1,451,000 for the same period a year ago, an increase of CAD 353,000. Net loss was significantly reduced from CAD 1,076,000 in the fourth quarter of 2013 to CAD 549,000 in the comparative quarter this year. For the year, revenues were lower for the year at CAD 6,788,000, compared with CAD 7,526,000 for 2013. The decrease in revenues is explained by fewer orders placed during the year by a large customer. This was partially offset by the installation of sensor systems from the 48-well contract from an oil and gas producer of SAGD oil sands project in Alberta, by increased revenues in the industrial field resulting from significant orders received from two existing customers and by licensing revenues arising from the Abiomed agreement. Net loss for fiscal year 2014 was CAD 3,099,000 compared with a net loss of CAD 2,366,000 for the same period last year. The increase in net loss mainly reflects the decrease in the gross margin, higher marketing expenses explained by higher headcount, higher advertising and tradeshows expenses and a negative variation in the change in fair value of embedded derivative. Net loss per diluted share was CAD 0.06 against CAD 0.05 a year ago.

Opsens Inc. Presents at SeeThruEquity Fall Microcap Investor Conference 2014, Nov-12-2014 09:30 AM

Opsens Inc. Presents at SeeThruEquity Fall Microcap Investor Conference 2014, Nov-12-2014 09:30 AM. Venue: Convene Midtown East, New York, New York, United States. Speakers: Louise E. Laflamme, Chief Executive Officer, President and Director.

Opsens Inc. Provides a Report on the Progress of its FFR Clinical and Regulatory Activities

Opsens Inc. provided a report on the progress of its FFR clinical and regulatory activities. Opsens received the authorization from Health Canada to conduct investigational testing in patients, pertaining to the conduct of a pilot study: "Opsens' OptoWire for Fractional Flow Reserve - The O2 pilot study". The objectives of the study are to "assess usability, functionality and safety of Opsens' OptoWire and OptoMonitor in patients with ischemic coronary artery disease who are referred for diagnostic angiography". Among the planned 50 patients to be enrolled, 27 have already been enrolled at Institut universitaire de cardiologie et de pneumologie de Québec - Quebec Heart and Lung Institute. Preliminary results presented during the Transcatheter Cardiovascular Therapeutics Conference in Washington indicate that all four primary endpoints of the study were completed with success. During a TCT session for Late Breaking Early Human Clinical Studies and Reports, Dr. Olivier F. Bertrand, Director of the International Chair on Interventional Cardiology and Transradial Approach and principal investigator of the O2 pilot study concluded that: 1) Fiber optic technology has allowed for the development of improved PCI-like floppy wire with exceptional pressure stability (no drift) and perfect connectivity; 2) OptoMonitor is easy to use and ready to be integrated in the cath lab with printing and recording capabilities, although direct connection to cath lab hemodynamic system is possible; and 3) Extended use of FFR and potential added clinical value should be investigated in various clinical scenarios. Opsens plans to continue enrollment of up to 50 patients to gather additional data on the OptoWire and OptoMonitor.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPS:CN C$0.60 CAD 0.00

OPS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OPS.
View Industry Companies
 

Industry Analysis

OPS

Industry Average

Valuation OPS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.9x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPSENS INC, please visit www.opsens.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.